Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CobiMax is a nutritional supplement developed by Parnasa Mediworld, formulated as a soft gelatin capsule for oral administration. It contains a combination of omega-3 fatty acids (specifically eicosapentaenoic acid and docosahexaenoic acid), coenzyme Q10, lycopene, and selenium. This combination is typically used to support cardiovascular health, provide antioxidant protection, and address nutritional deficiencies. Omega-3 fatty acids contribute to heart health and anti-inflammatory processes, coenzyme Q10 is essential for mitochondrial energy production, lycopene is a potent carotenoid antioxidant, and selenium is a trace mineral that acts as a cofactor for antioxidant enzymes like glutathione peroxidase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CobiMax.